Brief: Gsk Expects To Nearly Double The Number Of Cancer Medicines It Is Testing In Clinical Trials Next Year- WSJ
Today 07:39
BRIEF-Gsk Expects To Nearly Double The Number Of Cancer Medicines It Is Testing In Clinical Trials Next Year- WSJ Oct 27 (Reuters) -
GSK EXPECTS TO NEARLY DOUBLE THE NUMBER OF CANCER MEDICINES IT IS TESTING IN CLINICAL TRIALS NEXT YEAR- WSJ
Source text: [ID:https://tinyurl.com/y3ypzuab]
Further company coverage: GSK.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GSK
See all newsGSK to nearly double cancer drugs in trials next year, WSJ reports (updated)
GSK to nearly double cancer drugs in trials, WSJ reports
Brief: Gsk Expects To Nearly Double The Number Of Cancer Medicines It Is Testing In Clinical Trials Next Year- WSJ
GSK, Hansoh's bone cancer drug delays disease progression in late-stage China study
Director/PDMR Shareholding